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• There is a possibility that vasodilation occurs via the myogenic response of 
vascular smooth muscle or within the perivascular nerve plexus, but results do 
not lead to a definitive conclusion. 
• Lidocaine as a pharmacological tool could potentially play a role in exploring  
skeletal muscle blood flow in response to exercise, but the mechanisms for this 
are poorly understood5. 
• Exercise hyperemia in conjunction with the drug lidocaine may not be the 
answer in order to see the effects of vasodilation in human subjects.
• The vasodilator responses to exercise during lidocaine and saline infusion were 
not similar to the animal model findings and should be investigated further to 
make any conclusions4.
Discussion
• Rapid dilation is not blocked or attenuated by lidocaine in humans and further 
studies are needed to understand regulation of skeletal muscle blood flow.
Conclusions
Rapid vasodilation is studied extensively in skeletal muscle contractions, and 
vasodilation responses resulting from the action of muscle contractions can be 
conducted via the microcirculation starting in the small arterioles close to the 
capillaries and ascending into upstream feed arteries1,2,3. There are no current 
pharmacological tools that dependably block or attenuate vascular conducted 
responses in humans, but there is some evidence that propagated dilation was 
blocked by the local anesthetic lidocaine in animal studies4. If lidocaine can 
successfully block conducted dilation in humans, it could be used to address 
many issues related to skeletal muscle blood flow and metabolic control during 
exercise. This is significant because the mechanisms for skeletal muscle blood 
flow in response to exercise are poorly understood5. The aim of the study 
was to determine if lidocaine administration alters the vasodilator 
response to a brief forearm contraction. Three different doses of lidocaine 
at 1, 2, and 5 µg/100dL/min were infused into the brachial artery via a 20 ga
catheter. A single muscle contraction (SMC) at 40% of maximum voluntary 
contraction (MVC) was performed and forearm blood flow (FBF) was 
determined from brachial artery diameter and mean blood velocity measured 
using Doppler ultrasound. Forearm vascular conductance (FVC) was 
calculated from blood flow (ml/min) and blood pressure (mmHg). Total 
vasodilator responses with and without lidocaine did not show any significant 
differences at any dose. Change (D) in FVC with saline vs. 5 µg/100mL 
lidocaine infusion values (206 ± 33, 210 ± 27 mL×min-1×100mmHg-1, 
respectively) suggests that there was no significant change between differing 
drug doses. 
Introduction
Hemodynamic Responses
Saline
(µg/dL)
Lidocaine 1 
(µg/dL) 
Lidocaine 2 
(µg/dL)
Lidocaine 5 
(µg/dL)
Baseline
52.09 ± 9.57 40.00 ± 4.58 45.83 ± 3.97 43.02 ± 3.41
Peak
258.1 ± 41.59 223.0 ± 25.67 269.6 ± 37.37 252.9 ± 28.02
DFVC
206.0 ± 33.49 183.0 223.8 ± 34.5 209.8 ± 26.57
Area under the 
Curve (AUC) 5820 ± 1110 4933 ± 580 6116 ± 1055 4821 ± 512
Table 1. Values are means ± SEM for all 10 subjects. Lidocaine administration had no statistically 
significant effects on FVC or FBF during exercise. 
Methods
Experimental Timeline
Figure 1. Timeline for experimental protocol. The participant was instructed to perform a 1s 
contraction at 40% of MVC, followed by 5 minutes of recovery. Doses were increased after 
each 5 minute session and repeated SMC.
40% MVC Single Contraction
Figure 5. Representative response of one subject: FVC and cardiac cycle post-single muscle 
contraction following sequential infusions of saline (control) and lidocaine (1, 2 and 5 µg/100mL)
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Figure 4. Change in FVC after a brief SMC during sustained drug infusion was not 
significantly different between saline and lidocaine doses. Deltas were calculated by 
subtracting resting baseline FVC from post-contraction FVC. 
Change in Vasodilatory Responses
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Figure 2. Standard instrumentation 
setup for brachial arterial catheter 
placement in a human subject. A strain 
gauge was placed around the forearm 
for measurement of volume changes 
following saline (baseline) and lidocaine 
infusion.
Figure 3. Flow-mediated dilation 
technique using Doppler ultrasound and 
a handgrip device set to 40% of MVC. 
The participant was infused with saline 
and the respective dose of lidocaine 
with ultrasound guidance to view 
brachial artery responses.
• 10 healthy human participants between the ages of 18-40 years old who fasted 
for 4 hours prior to the study were instrumented with a 3-lead ECG to measure 
heart rate. A 20 ga catheter was placed in the brachial artery under aseptic 
conditions for beat-by-beat blood arterial monitoring and drug infusions. 
• A Doppler ultrasound image was taken of the brachial artery in the subjects’ 
arms. Forearm volume was also measured via volume displacement and a 
maximum voluntary contraction was performed using a handgrip dynamometer. 
• FBF was determined by measurements of brachial artery mean blood velocity 
(MBV) and vessel diameter. The echo-Doppler, a hand-held 10.5 MHz linear 
probe operating in B-mode, was positioned over the brachial artery and blood 
flow was calculated as FBF = MBV x r2, where r is the vessel radius. FVC was 
then calculated as FVC = FBF/MAP x 100, expressed in mL/min/100mmHg.
• Forearm tissue volume (FAV) was used to determine the rate for drug infusion 
for saline and lidocaine. Subjects performed a single 1 second contraction at 
40% of MVC three times over the study period with 5 minutes of rest between 
the respective lidocaine infusions of 1, 2, and 5 µg/100mL (Figure 1). 
Figure 1. Timeline for sequence of events for each subject. The participant was instructed to perform a 1s contraction at 
40% max, followed by 5 minutes of recovery. Doses are increased after each 5 minute session and repeat the MVC.
• Healthy human participants between the ages of 18-40 years old who 
fasted for 4 hours prior to the study were instrumented with a 3-lead ECG 
to measure heart rate. A brachial artery catheter was placed under aseptic 
conditions for beat-by-beat blood arterial monitoring and drug infusions. 
• A Doppler ultrasound image was taken of the brachial artery in the 
subjects’ arms. Forearm volume was also measured via volume 
displacement and a maximum voluntary contraction was performed using 
a handgrip dynamometer. 
• Forearm blood flow (FBF) was determined by measurements of brachial 
artery mean blood velocity (MBV) and vessel diameter. The echo-Doppler, 
a hand-held 10.5 MHz linear probe operating in B-mode, was positioned 
over the brachial artery and blood flow was calculated as FBF = MBV x r2, 
where r is the vessel radius. Forearm vascular conductance (FVC) was 
then calculated as FVC = FBF/MAP x 100, expressed in 
mL/min/100mmHg.
• Forearm tissue volume (FAV) was used to determine the rate for drug 
infusion for saline and lidocaine. Subjects performed a single 1 second 
contraction at 40% of MVC three times over the study period with 5 
minutes of rest between the respective lidocaine infusions of 1, 2, and 5 
µg/100mL (Figure 3). 
Methods
Figure 1. Standard instrumentation 
setup for brachial arterial catheter 
placement in a human subject. A strain 
gauge was placed around the forearm 
for measurement of volume changes 
following saline (baseline) and 
lidocaine infusion.
Figure 2. Flow-mediated dilation 
technique using Doppler ultrasound 
and a handgrip device set to 40% of 
MVC. The participant was infused with 
saline and the respective dose of 
lidocaine with ultrasound guidance to 
view brachial artery responses.
